{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:22:22Z","timestamp":1786519342999,"version":"build-2736575974"},"reference-count":100,"publisher":"Institute of Physiology of the Czech Academy of Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiol Res"],"abstract":"<jats:p>Down Syndrome (Ds) is the most common chromosomal cause of intellectual disability that results from triplication of chromosome 21 genes. Individuals with Ds demonstrate cognitive deficits in addition to comorbidities including cardiac defects, pulmonary arterial hypertension (PAH), low blood pressure (BP), and differences in autonomic regulation. Many individuals with Ds are born with heart malformations and some can be surgically corrected. Lower BP at rest and in response to exercise and other stressors are a prevalent feature in Ds. These reduced cardiovascular responses may be due to underlying autonomic dysfunction and have been implicated in lower exercise\/work capacity in Ds, which is an important correlate of morbidity, mortality and quality of life. Exercise therapy can be beneficial to normalize autonomic function and may help prevent the development of co-morbidities in Ds. We will review cardiovascular physiology and pathophysiology in individuals with Ds, along with exercise therapy and special considerations for these individuals.<\/jats:p>","DOI":"10.33549\/physiolres.934791","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:26:10Z","timestamp":1648211170000},"page":"1-16","source":"Crossref","is-referenced-by-count":15,"title":["Cardiovascular Physiology and Pathophysiology in Down Syndrome"],"prefix":"10.33549","author":[{"given":"B","family":"CILHOROZ","sequence":"first","affiliation":[{"name":"Department of Exercise Sciences, Syracuse University, Syracuse, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"RECENO","sequence":"additional","affiliation":[{"name":"Department of Exercise Science and Athletic Training, Ithaca, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"HEFFERNAN","sequence":"additional","affiliation":[{"name":"Department of Exercise Sciences, Syracuse University, Syracuse, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"DERUISSEAU","sequence":"additional","affiliation":[{"name":"Department of Exercise Sciences, Syracuse University, Syracuse, New York, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"19169","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"Mai CT, Isenburg JL, Canfield MA, Meyer RE, Correa A, Alverson CJ, Lupo PJ, Riehle-Colarusso T, Cho SJ, Aggarwal D, Kirby RS. National population-based estimates for major birth defects, 2010-2014. Birth Defects Res 2019;111:1420-1435. https:\/\/doi.org\/10.1002\/bdr2.1589","DOI":"10.1002\/bdr2.1589"},{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Allen G, Benda CE, B\u00f6\u00f6k JA, Carter CO, Ford CE, Chu EH, Hanhart E, Jervis G, Langdon-Down W, Lejeune J, Nishimura H, Oster J, Penrose LS, Polani PE, Potter EL, Stern C, Turpin R, Warkany J, Yannet H. Mongolism. Am J Hum Genet 1961;13:426. https:\/\/doi.org\/10.1016\/S0140-6736(61)92939-7","DOI":"10.1016\/s0140-6736(61)92939-7"},{"key":"ref2","unstructured":"Lejeune J, Gauthier M, Turpin R. Les chromosomes humains en culture de tissus [Human chromosomes in tissue cultures]. (Article in French) C R Hebd Seances Acad Sci 1959;248:602-603."},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Santoro SL, Steffensen EH. Congenital heart disease in Down syndrome - A review of temporal changes. J Congenit Heart Dis 2021;5:1-14. https:\/\/doi.org\/10.1186\/s40949-020-00055-7","DOI":"10.1186\/s40949-020-00055-7"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Suzuki J, Takaku A. Cerebrovascular \"moyamoya\" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 1969;20:288-299. https:\/\/doi.org\/10.1001\/archneur.1969.00480090076012","DOI":"10.1001\/archneur.1969.00480090076012"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Rodrigues AN, Coelho LC, Goncalves WL, Gouvea SA, Vasconcellos MJ, Cunha RS, Abreu GR. Stiffness of the large arteries in individuals with and without Down syndrome. Vasc Health Risk Manag 2011;7:375-381. https:\/\/doi.org\/10.2147\/VHRM.S21273","DOI":"10.2147\/vhrm.s21273"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Bunsawat K, Baynard T. Cardiac autonomic modulation and blood pressure responses to isometric handgrip and submaximal cycling exercise in individuals with Down syndrome. Clin Auton Res 2016;26:253-260. https:\/\/doi.org\/10.1007\/s10286-016-0361-y","DOI":"10.1007\/s10286-016-0361-y"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Fernhall B, Otterstetter M. Attenuated responses to sympathoexcitation in individuals with Down syndrome. J Appl Physiol (1985) 2003;94:2158-2165. https:\/\/doi.org\/10.1152\/japplphysiol.00959.2002","DOI":"10.1152\/japplphysiol.00959.2002"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Zigman WB. Atypical aging in Down syndrome. Dev Disabil Res Rev 2013;18:51-67. https:\/\/doi.org\/10.1002\/ddrr.1128","DOI":"10.1002\/ddrr.1128"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Sobey CG, Judkins CP, Sundararajan V, Phan TG, Drummond GR, Srikanth VK. Risk of major cardiovascular events in people with Down syndrome. PLoS One 2015;10:e0137093. https:\/\/doi.org\/10.1371\/journal.pone.0137093","DOI":"10.1371\/journal.pone.0137093"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Bittles AH, Glasson EJ. Clinical, social, and ethical implications of changing life expectancy in Down syndrome. Dev Med Child Neurol 2004;46:282-286. https:\/\/doi.org\/10.1017\/S0012162204000441","DOI":"10.1017\/s0012162204000441"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Weijerman ME, de Winter JP. Clinical practice. The care of children with Down syndrome. Eur J Pediatr 2010;169:1445-1452. https:\/\/doi.org\/10.1007\/s00431-010-1253-0","DOI":"10.1007\/s00431-010-1253-0"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Tsou AY, Bulova P, Capone G, Chicoine B, Gelaro B, Harville TO, Martin BA, McGuire DE, McKelvey KD, Peterson M, Tyler C, Wells M, Whitten MS. Medical care of adults with Down syndrome: A clinical guideline. JAMA 2020;324:1543-1556. https:\/\/doi.org\/10.1001\/jama.2020.17024","DOI":"10.1001\/jama.2020.17024"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Bull MJ. Down Syndrome. N Engl J Med 2020;382:2344-2352. https:\/\/doi.org\/10.1056\/NEJMra1706537","DOI":"10.1056\/NEJMra1706537"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Yang Q, Rasmussen SA, Friedman JM. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet 2002;359:1019-1025. https:\/\/doi.org\/10.1016\/S0140-6736(02)08092-3","DOI":"10.1016\/s0140-6736(02)08092-3"},{"key":"ref15","doi-asserted-by":"publisher","unstructured":"Alexander M, Petri H, Ding Y, Wandel C, Khwaja O, Foskett N. Morbidity and medication in a large population of individuals with Down syndrome compared to the general population. Dev Med Child Neurol 2016;58:246-254. https:\/\/doi.org\/10.1111\/dmcn.12868","DOI":"10.1111\/dmcn.12868"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Landes SD, Stevens JD, Turk MA. Cause of death in adults with Down syndrome in the United States. Disabil Health J 2020;13:100947. https:\/\/doi.org\/10.1016\/j.dhjo.2020.100947","DOI":"10.1016\/j.dhjo.2020.100947"},{"key":"ref17","unstructured":"Head E, Powell D, Gold BT, Schmitt FA. Alzheimer's Disease in Down Syndrome. Eur J Neurodegener Dis 2012;1:353-364."},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Santoro M, Coi A, Spadoni I, Bianchi F, Pierini A. Sex differences for major congenital heart defects in Down Syndrome: A population based study. Eur J Med Genet 2018;61:546-550. https:\/\/doi.org\/10.1016\/j.ejmg.2018.05.013","DOI":"10.1016\/j.ejmg.2018.05.013"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Roizen NJ, Patterson D. Down's syndrome. Lancet 2003;361:1281-1289. https:\/\/doi.org\/10.1016\/S0140-6736(03)12987-X","DOI":"10.1016\/s0140-6736(03)12987-x"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Esbensen AJ. Health conditions associated with aging and end of life of adults with Down syndrome. Int Rev Res Ment Retard 2010;39:107-126. https:\/\/doi.org\/10.1016\/S0074-7750(10)39004-5","DOI":"10.1016\/s0074-7750(10)39004-5"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"D'Alto M, Mahadevan VS. Pulmonary arterial hypertension associated with congenital heart disease. Eur Respir Rev 2012;21:328-337. https:\/\/doi.org\/10.1183\/09059180.00004712","DOI":"10.1183\/09059180.00004712"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Hijii T, Fukushige J, Igarashi H, Takahashi N, Ueda K. Life expectancy and social adaptation in individuals with Down syndrome with and without surgery for congenital heart disease. Clin Pediatr (Phila) 1997;36:327-332. https:\/\/doi.org\/10.1177\/000992289703600603","DOI":"10.1177\/000992289703600603"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Formigari R, Di Donato RM, Gargiulo G, Di Carlo D, Feltri C, Picchio FM, Marino B. Better surgical prognosis for patients with complete atrioventricular septal defect and Down's syndrome. Ann Thorac Surg 2004;78:666-672. https:\/\/doi.org\/10.1016\/j.athoracsur.2003.12.021","DOI":"10.1016\/j.athoracsur.2003.12.021"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. I. Br Med J 1958;2:701-709. https:\/\/doi.org\/10.1136\/bmj.2.5098.701","DOI":"10.1136\/bmj.2.5098.701"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"K\u00f6rten MA, Helm PC, Abdul-Khaliq H, Baumgartner H, Kececioglu D, Schlensak C, Bauer UM, Diller GP. Eisenmenger syndrome and long-term survival in patients with Down syndrome and congenital heart disease. Heart 2016;102:1552-1557. https:\/\/doi.org\/10.1136\/heartjnl-2016-309437","DOI":"10.1136\/heartjnl-2016-309437"},{"key":"ref26","unstructured":"Korenberg JR, Bradley C, Disteche CM. Down syndrome: molecular mapping of the congenital heart disease and duodenal stenosis. Am J Hum Genet 1992;50:294-302."},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Ferri R, Curzi-Dascalova L, Del Gracco S, Elia M, Musumeci SA, Pettinato S. Heart rate variability and apnea during sleep in Down's syndrome. J Sleep Res 1998;7:282-287. https:\/\/doi.org\/10.1046\/j.1365-2869.1998.00111.x","DOI":"10.1046\/j.1365-2869.1998.00111.x"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"Grossman TR, Gamliel A, Wessells RJ, Taghli-Lamallem O, Jepsen K, Ocorr K, Korenberg JR, Peterson KL, Rosenfeld MG, Bodmer R, Bier E. Over-expression of DSCAM and COL6A2 cooperatively generates congenital heart defects. PLoS Genet 2011;7:e1002344. https:\/\/doi.org\/10.1371\/journal.pgen.1002344","DOI":"10.1371\/journal.pgen.1002344"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Davies GE, Howard CM, Gorman LM, Farrer MJ, Holland AJ, Williamson R, Kessling AM. Polymorphisms and linkage disequilibrium in the COL6A1 and COL6A2 gene cluster: novel DNA polymorphisms in the region of a candidate gene for congenital heart defects in Down's syndrome. Hum Genet 1993;90:521-525. https:\/\/doi.org\/10.1007\/BF00217452","DOI":"10.1007\/bf00217452"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Lange AW, Molkentin JD, Yutzey KE. DSCR1 gene expression is dependent on NFATc1 during cardiac valve formation and colocalizes with anomalous organ development in trisomy 16 mice. Dev Biol 2004;266:346-360. https:\/\/doi.org\/10.1016\/j.ydbio.2003.10.036","DOI":"10.1016\/j.ydbio.2003.10.036"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Barlow GM, Chen XN, Shi ZY, Lyons GE, Kurnit DM, Celle L, Spinner NB, Zackai E, Pettenati MJ, Van Riper AJ, Vekemans MJ, Mjaatvedt CH, Korenberg JR. Down syndrome congenital heart disease: a narrowed region and a candidate gene. Genet Med 2001;3:91-101. https:\/\/doi.org\/10.1097\/00125817-200103000-00002","DOI":"10.1097\/00125817-200103000-00002"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Wright TC, Orkin RW, Destrempes M, Kurnit DM. Increased adhesiveness of Down syndrome fetal fibroblasts in vitro. Proc Natl Acad Sci U S A 1984;81:2426-2430. https:\/\/doi.org\/10.1073\/pnas.81.8.2426","DOI":"10.1073\/pnas.81.8.2426"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Gittenberger-de Groot AC, Bartram U, Oosthoek PW, Bartelings MM, Hogers B, Poelmann RE, Jongewaard IN, Klewer SE. Collagen type VI expression during cardiac development and in human fetuses with trisomy 21. Anat Rec A Discov Mol Cell Evol Biol 2003;275:1109-1116. https:\/\/doi.org\/10.1002\/ar.a.10126","DOI":"10.1002\/ar.a.10126"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"De La Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR, Mak TW. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature 1998;392:182-186. https:\/\/doi.org\/10.1038\/32419","DOI":"10.1038\/32419"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 2018;9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402","DOI":"10.3389\/fendo.2018.00402"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Br\u00e1s A, Rodrigues AS, Gomes B, Rueff J. Down syndrome and microRNAs. Biomed Rep 2018;8:11-16. https:\/\/doi.org\/10.3892\/br.2017.1019","DOI":"10.3892\/br.2017.1019"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Coppola A, Romito A, Borel C, Gehrig C, Gagnebin M, Falconnet E, Izzo A, Altucci L, Banfi S, Antonarakis SE, Minchiotti G, Cobellis G. Cardiomyogenesis is controlled by the miR-99a\/let-7c cluster and epigenetic modifications. Stem Cell Res 2014;12:323-337. https:\/\/doi.org\/10.1016\/j.scr.2013.11.008","DOI":"10.1016\/j.scr.2013.11.008"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Ackerman C, Locke AE, Feingold E, Reshey B, Espana K, Thusberg J, Mooney S, Bean LJ, Dooley KJ, Cua CL, Reeves RH, Sherman SL, Maslen CL. An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet 2012;91:646-659. https:\/\/doi.org\/10.1016\/j.ajhg.2012.08.017","DOI":"10.1016\/j.ajhg.2012.08.017"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Thomas NA, Koudijs M, van Eeden FJ, Joyner AL, Yelon D. Hedgehog signaling plays a cell-autonomous role in maximizing cardiac developmental potential. Development 2008;135:3789-3799. https:\/\/doi.org\/10.1242\/dev.024083","DOI":"10.1242\/dev.024083"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Chen YQ, Li T, Guo WY, Su FJ, Zhang YX. Identification of altered pathways in Down syndrome-associated congenital heart defects using an individualized pathway aberrance score. Genet Mol Res 2016;15. https:\/\/doi.org\/10.4238\/gmr.15027601","DOI":"10.4238\/gmr.15027601"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Goddeeris MM, Rho S, Petiet A, Davenport CL, Johnson GA, Meyers EN, Klingensmith J. Intracardiac septation requires hedgehog-dependent cellular contributions from outside the heart. Development 2008;135:1887-1895. https:\/\/doi.org\/10.1242\/dev.016147","DOI":"10.1242\/dev.016147"},{"key":"ref42","doi-asserted-by":"publisher","unstructured":"Zhang H, Liu L, Tian J. Molecular mechanisms of congenital heart disease in Down syndrome. Genes Dis 2019;6:372-377. https:\/\/doi.org\/10.1016\/j.gendis.2019.06.007","DOI":"10.1016\/j.gendis.2019.06.007"},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Al-Biltagi MA. Echocardiography in children with Down syndrome. World J Clin Pediatr 2013;2:36-45. https:\/\/doi.org\/10.5409\/wjcp.v2.i4.36","DOI":"10.5409\/wjcp.v2.i4.36"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Saffirio C, Marino B, Formigari R. Better surgical prognosis for patients with Down syndrome. J Thorac Cardiovasc Surg 2008;135:230. https:\/\/doi.org\/10.1016\/j.jtcvs.2007.07.065","DOI":"10.1016\/j.jtcvs.2007.07.065"},{"key":"ref45","unstructured":"Takeuchi K. Hypoplasia of bilateral internal carotid arteries. Brain Nerve 1957;9:37-43."},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"See AP, Ropper AE, Underberg DL, Robertson RL, Scott RM, Smith ER. Down syndrome and moyamoya: clinical presentation and surgical management. J Neurosurg Pediatr 2015;16:58-63. https:\/\/doi.org\/10.3171\/2014.12.PEDS14563","DOI":"10.3171\/2014.12.peds14563"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Santoro JD, Lee S, Mlynash M, Nguyen T, Lazzareschi DV, Kraler LD, Mayne EW, Steinberg GK. Blood pressure elevation and risk of moyamoya syndrome in patients with trisomy 21. Pediatrics 2018;142:e20180840. https:\/\/doi.org\/10.1542\/peds.2018-0840","DOI":"10.1542\/peds.2018-0840"},{"key":"ref48","doi-asserted-by":"publisher","unstructured":"Jea A, Smith ER, Robertson R, Scott RM. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 2005;116:e694-e701. https:\/\/doi.org\/10.1542\/peds.2005-0568","DOI":"10.1542\/peds.2005-0568"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Tavares Bello C, Barreiros C, Gil I, Vasconcelos C. Down syndrome and Moyamoya disease: unusual cause of stroke. BMJ Case Rep 2017;2017:bcr2017219894. https:\/\/doi.org\/10.1136\/bcr-2017-219894","DOI":"10.1136\/bcr-2017-219894"},{"key":"ref50","doi-asserted-by":"publisher","unstructured":"Melville CA, Cooper SA, McGrother CW, Thorp CF, Collacott R. Obesity in adults with Down syndrome: a case-control study. J Intellect Disabil Res 2005;49:125-133. https:\/\/doi.org\/10.1111\/j.1365-2788.2004.00616.x","DOI":"10.1111\/j.1365-2788.2004.00616.x"},{"key":"ref51","doi-asserted-by":"publisher","unstructured":"Dierssen M, Fructuoso M, Mart\u00ednez de Lagr\u00e1n M, Perluigi M, Barone E. Down syndrome is a metabolic disease: Altered insulin signaling mediates peripheral and brain dysfunctions. Front Neurosci 2020;14:670. https:\/\/doi.org\/10.3389\/fnins.2020.00670","DOI":"10.3389\/fnins.2020.00670"},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"Hsieh K, Hilgenkamp TIM, Murthy S, Heller T, Rimmer JH. Low levels of physical activity and sedentary behavior in adults with intellectual disabilities. Int J Environ Res Public Health 2017;14:1503. https:\/\/doi.org\/10.3390\/ijerph14121503","DOI":"10.3390\/ijerph14121503"},{"key":"ref53","doi-asserted-by":"publisher","unstructured":"D\u00f6rner K, Gaethke AS, Tolksdorf M, Schumann KP, Gustmann H. Cholesterol fractions and triglycerides in children and adults with Down's syndrome. Clin Chim Acta 1984;142:307-311. https:\/\/doi.org\/10.1016\/0009-8981(84)90267-5","DOI":"10.1016\/0009-8981(84)90267-5"},{"key":"ref54","doi-asserted-by":"publisher","unstructured":"Head E, Phelan MJ, Doran E, Kim RC, Poon WW, Schmitt FA, Lott IT. Cerebrovascular pathology in Down syndrome and Alzheimer disease. Acta Neuropathol Commun 2017;5:93. https:\/\/doi.org\/10.1186\/s40478-017-0499-4","DOI":"10.1186\/s40478-017-0499-4"},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Murdoch JC, Rodger JC, Rao SS, Fletcher CD, Dunnigan MG. Down's syndrome: an atheroma-free model? Br Med J 1977;2:226-228. https:\/\/doi.org\/10.1136\/bmj.2.6081.226","DOI":"10.1136\/bmj.2.6081.226"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Parra P, Costa R, de As\u00faa DR, Moldenhauer F, Su\u00e1rez C. Atherosclerotic surrogate markers in adults with Down syndrome: A case-control study. J Clin Hypertens 2017;19:205-211. https:\/\/doi.org\/10.1111\/jch.12890","DOI":"10.1111\/jch.12890"},{"key":"ref57","doi-asserted-by":"publisher","unstructured":"Draheim CC, Geijer JR, Dengel DR. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. Am J Cardiol 2010;106:1512-1516. https:\/\/doi.org\/10.1016\/j.amjcard.2010.06.079","DOI":"10.1016\/j.amjcard.2010.06.079"},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Cappelli-Bigazzi M, Santoro G, Battaglia C, Palladino MT, Carrozza M, Russo MG, Pacileo G, Calabr\u00f2 R. Endothelial cell function in patients with Down's syndrome. Am J Cardiol 2004;94:392-395. https:\/\/doi.org\/10.1016\/j.amjcard.2004.04.047","DOI":"10.1016\/j.amjcard.2004.04.047"},{"key":"ref59","doi-asserted-by":"publisher","unstructured":"Perepitchka M, Galat Y, Beletsky IP, Iannaccone PM, Galat V. Down syndrome iPSC model: endothelial perspective on tumor development. Oncotarget 2020;11:3387-3404. https:\/\/doi.org\/10.18632\/oncotarget.27712","DOI":"10.18632\/oncotarget.27712"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Yoder MC. Human endothelial progenitor cells. Cold Spring Harb Perspect Med 2012;2:a006692. https:\/\/doi.org\/10.1101\/cshperspect.a006692","DOI":"10.1101\/cshperspect.a006692"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Costa V, Sommese L, Casamassimi A, Colicchio R, Angelini C, Marchesano V, Milone L, Farzati B, Giovane A, Fiorito C, Rienzo M, Picardi M, Avallone B, Marco Corsi M, Sarubbi B, Calabr\u00f2 R, Salvatore P, Ciccodicola A, Napoli C. Impairment of circulating endothelial progenitors in Down syndrome. BMC Med Genomics 2010;3:40. https:\/\/doi.org\/10.1186\/1755-8794-3-40","DOI":"10.1186\/1755-8794-3-40"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Mossello E, Pieraccioli M, Nesti N, Bulgaresi M, Lorenzi C, Caleri V, Tonon E, Cavallini MC, Baroncini C, Di Bari M, Baldasseroni S, Cantini C, Biagini CA, Marchionni N, Ungar A. Effects of low blood pressure in cognitively impaired elderly patients treated with antihypertensive drugs. JAMA Intern Med 2015;175:578-585. https:\/\/doi.org\/10.1001\/jamainternmed.2014.8164","DOI":"10.1001\/jamainternmed.2014.8164"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Nilsson SE, Read S, Berg S, Johansson B, Melander A, Lindblad U. Low systolic blood pressure is associated with impaired cognitive function in the oldest old: longitudinal observations in a population-based sample 80 years and older. Aging Clin Exp Res 2007;19:41-47. https:\/\/doi.org\/10.1007\/BF03325209","DOI":"10.1007\/bf03325209"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Thalman S, Van Pelt KL, Lin AL, Johnson NF, Jicha G, Caban-Holt A, Robertson W, Lightner D, Powell D, Head E, Schmitt F. A preliminary study of cerebral blood flow, aging and dementia in people with Down syndrome. J Intellect Disabil Res 2020;64:934-945. https:\/\/doi.org\/10.1111\/jir.12784","DOI":"10.1111\/jir.12784"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Hithersay R, Hamburg S, Knight B, Strydom A. Cognitive decline and dementia in Down syndrome. Curr Opin Psychiatry 2017;30:102-107. https:\/\/doi.org\/10.1097\/YCO.0000000000000307","DOI":"10.1097\/yco.0000000000000307"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Iellamo F, Galante A, Legramante JM, Lippi ME, Condoluci C, Albertini G, Volterrani M. Altered autonomic cardiac regulation in individuals with Down syndrome. Am J Physiol Heart Circ Physiol 2005;289:H2387-H2391. https:\/\/doi.org\/10.1152\/ajpheart.00560.2005","DOI":"10.1152\/ajpheart.00560.2005"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Heffernan KS, Baynard T, Goulopoulou S, Giannopoulou I, Collier SR, Figueroa A, Fernhall B. Baroreflex sensitivity during static exercise in individuals with Down syndrome. Med Sci Sports Exerc 2005;37:2026-2031. https:\/\/doi.org\/10.1249\/01.mss.0000179217.59831.41","DOI":"10.1249\/01.mss.0000179217.59831.41"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"McCraty R, Shaffer F. Heart rate variability: New perspectives on physiological mechanisms, assessment of self-regulatory capacity, and health risk. Glob Adv Health Med. 2015;4:46-61. https:\/\/doi.org\/10.7453\/gahmj.2014.073","DOI":"10.7453\/gahmj.2014.073"},{"key":"ref69","doi-asserted-by":"publisher","unstructured":"Heathers JA. Everything hertz: Methodological issues in short-term frequency-domain HRV. Front Physiol 2014;5:177. https:\/\/doi.org\/10.3389\/fphys.2014.00177","DOI":"10.3389\/fphys.2014.00177"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Lee ST, Hon EH. The fetal electrocardiogram. Iv. Unusual variations in the Qrs complex during labor. Am J Obstet Gynecol 1965;92:1140-1148. https:\/\/doi.org\/10.1016\/S0002-9378(15)33098-2","DOI":"10.1016\/S0002-9378(15)33098-2"},{"key":"ref71","doi-asserted-by":"publisher","unstructured":"Pumprla J, Howorka K, Groves D, Chester M, Nolan J. Functional assessment of heart rate variability: physiological basis and practical applications. Int J Cardiol 2002;84:1-14. https:\/\/doi.org\/10.1016\/S0167-5273(02)00057-8","DOI":"10.1016\/s0167-5273(02)00057-8"},{"key":"ref72","doi-asserted-by":"publisher","unstructured":"Mourot L, Bouhaddi M, Tordi N, Rouillon JD, Regnard J. Short- and long-term effects of a single bout of exercise on heart rate variability: comparison between constant and interval training exercises. Eur J Appl Physiol 2004;92:508-517. https:\/\/doi.org\/10.1007\/s00421-004-1119-0","DOI":"10.1007\/s00421-004-1119-0"},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Baynard T, Pitetti KH, Guerra M, Fernhall B. Heart rate variability at rest and during exercise in persons with Down syndrome. Arch Phys Med Rehabil 2004;85:1285-1290. https:\/\/doi.org\/10.1016\/j.apmr.2003.11.023","DOI":"10.1016\/j.apmr.2003.11.023"},{"key":"ref74","doi-asserted-by":"publisher","unstructured":"Goulopoulou S, Baynard T, Collier S, Giannopoulou I, Figueroa A, Beets M, Pitetti K, Fernhall B. Cardiac autonomic control in individuals with Down syndrome. Am J Ment Retard 2006;111:27-34. https:\/\/doi.org\/10.1352\/0895-8017(2006)111[27:CACIIW]2.0.CO;2","DOI":"10.1352\/0895-8017(2006)111[27:caciiw]2.0.co;2"},{"key":"ref75","doi-asserted-by":"publisher","unstructured":"Shaffer F, Ginsberg JP. An overview of heart rate variability metrics and norms. Front Public Health 2017;5:258. https:\/\/doi.org\/10.3389\/fpubh.2017.00258","DOI":"10.3389\/fpubh.2017.00258"},{"key":"ref76","doi-asserted-by":"publisher","unstructured":"Hendrix JA, Amon A, Abbeduto L, Agiovlasitis S, Alsaied T, Anderson HA, Bain LJ, Baumer N, Bhattacharyya A, Bogunovic D, Botteron KN, Capone G, Chandan P, Chase I, Chicoine B, Cieuta-Walti C, DeRuisseau LR, Durand S, Esbensen A, Fortea J, ET AL. Opportunities, barriers, and recommendations in Down syndrome research. Transl Sci Rare Dis 2021;5:99-129. https:\/\/doi.org\/10.3233\/TRD-200090","DOI":"10.3233\/trd-200090"},{"key":"ref77","doi-asserted-by":"publisher","unstructured":"Gonz\u00e1lez-Ag\u00fcero A, Vicente-Rodr\u00edguez G, Moreno LA, Guerra-Balic M, Ara I, Casaj\u00fas JA. Health-related physical fitness in children and adolescents with Down syndrome and response to training. Scand J Med Sci Sports 2010;20:716-724. https:\/\/doi.org\/10.1111\/j.1600-0838.2010.01120.x","DOI":"10.1111\/j.1600-0838.2010.01120.x"},{"key":"ref78","doi-asserted-by":"publisher","unstructured":"Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 1995;11:177-184. https:\/\/doi.org\/10.1038\/ng1095-177","DOI":"10.1038\/ng1095-177"},{"key":"ref79","doi-asserted-by":"publisher","unstructured":"Cunha AS, Silva-Filho AC, Dias CJ, Durans R, Brito-Monzani JDO, Rodrigues B, Mostarda CT. Impacts of low or vigorous levels of physical activity on body composition, hemodynamics and autonomic modulation in Down syndrome subjects. Motriz: Revista de Educa\u00e7\u00e3o F\u00edsica 2018;24:e1018132. https:\/\/doi.org\/10.1590\/s1980-6574201800010013","DOI":"10.1590\/s1980-6574201800010013"},{"key":"ref80","unstructured":"Davisson MT, Schmidt C, Reeves RH, Irving NG, Akeson EC, Harris BS, Bronson RT. Segmental trisomy as a mouse model for Down syndrome. Prog Clin Biol Res 1993;384:117-133."},{"key":"ref81","doi-asserted-by":"publisher","unstructured":"Delabar JM, Theophile D, Rahmani Z, Chettouh Z, Blouin JL, Prieur M, Noel B, Sinet PM. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur J Hum Genet 1993;1:114-124. https:\/\/doi.org\/10.1159\/000472398","DOI":"10.1159\/000472398"},{"key":"ref82","doi-asserted-by":"publisher","unstructured":"Ruparelia A, Pearn ML, Mobley WC. Aging and intellectual disability: insights from mouse models of Down syndrome. Dev Disabil Res Rev 2013;18:43-50. https:\/\/doi.org\/10.1002\/ddrr.1127","DOI":"10.1002\/ddrr.1127"},{"key":"ref83","doi-asserted-by":"publisher","unstructured":"Moore CS, Roper RJ. The power of comparative and developmental studies for mouse models of Down syndrome. Mamm Genome 2007;18:431-443. https:\/\/doi.org\/10.1007\/s00335-007-9030-8","DOI":"10.1007\/s00335-007-9030-8"},{"key":"ref84","doi-asserted-by":"publisher","unstructured":"Kazuki Y, Gao FJ, Li Y, Moyer AJ, Devenney B, Hiramatsu K, Miyagawa-Tomita S, Abe S, Kazuki K, Kajitani N, Uno N, Takehara S, Takiguchi M, Yamakawa M, Hasegawa A, Shimizu R, Matsukura S, Noda N, Ogonuki N, Inoue K, ET AL. A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21. Elife 2020;9:e56223. https:\/\/doi.org\/10.7554\/eLife.56223","DOI":"10.7554\/elife.56223.sa2"},{"key":"ref85","doi-asserted-by":"publisher","unstructured":"Nakano-Kobayashi A, Awaya T, Kii I, Sumida Y, Okuno Y, Yoshida S, Sumida T, Inoue H, Hosoya T, Hagiwara M. Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice. Proc Natl Acad Sci U S A 2017;114:10268-10273. https:\/\/doi.org\/10.1073\/pnas.1704143114","DOI":"10.1073\/pnas.1704143114"},{"key":"ref86","doi-asserted-by":"publisher","unstructured":"Belichenko NP, Belichenko PV, Kleschevnikov AM, Salehi A, Reeves RH, Mobley WC. The \"Down syndrome critical region\" is sufficient in the mouse model to confer behavioral, neurophysiological, and synaptic phenotypes characteristic of Down syndrome. J Neurosci 2009;29:5938-5948. https:\/\/doi.org\/10.1523\/JNEUROSCI.1547-09.2009","DOI":"10.1523\/jneurosci.1547-09.2009"},{"key":"ref87","doi-asserted-by":"publisher","unstructured":"DeRuisseau LR, Receno CN, Heffernan KS, Cunningham CM. Heart rate and blood pressure in male Ts65Dn mice: a model to investigate cardiovascular responses in Down syndrome. Physiol Rep 2019;7:e14205. https:\/\/doi.org\/10.14814\/phy2.14205","DOI":"10.14814\/phy2.14205"},{"key":"ref88","doi-asserted-by":"publisher","unstructured":"Williams AD, Mjaatvedt CH, Moore CS. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn 2008;237:426-435. https:\/\/doi.org\/10.1002\/dvdy.21416","DOI":"10.1002\/dvdy.21416"},{"key":"ref89","doi-asserted-by":"publisher","unstructured":"Figueroa A, Collier SR, Baynard T, Giannopoulou I, Goulopoulou S, Fernhall B. Impaired vagal modulation of heart rate in individuals with Down syndrome. Clin Auton Res 2005;15:45-50. https:\/\/doi.org\/10.1007\/s10286-005-0235-1","DOI":"10.1007\/s10286-005-0235-1"},{"key":"ref90","doi-asserted-by":"publisher","unstructured":"De Carvalho TD, de Abreu LC, Mustacchi Z, Vanderlei LC, Godoy MF, Raimundo RD, Ferreira Filho C, da Silva TD, Guilhoto L, Perico V, Finotti VR, Ferreira C. Cardiac autonomic modulation of children with Down syndrome. Pediatr Cardiol 2015;36:344-349. https:\/\/doi.org\/10.1007\/s00246-014-1012-5","DOI":"10.1007\/s00246-014-1012-5"},{"key":"ref91","doi-asserted-by":"publisher","unstructured":"Raveau M, Lignon JM, Nalesso V, Duchon A, Groner Y, Sharp AJ, Dembele D, Brault V, H\u00e9rault Y. The App-Runx1 region is critical for birth defects and electrocardiographic dysfunctions observed in a Down syndrome mouse model. PLoS Genet 2012;8:e1002724. https:\/\/doi.org\/10.1371\/journal.pgen.1002724","DOI":"10.1371\/journal.pgen.1002724"},{"key":"ref92","doi-asserted-by":"publisher","unstructured":"Henkens IR, Mouchaers KT, Vliegen HW, van der Laarse WJ, Swenne CA, Maan AC, Draisma HH, Schalij I, van der Wall EE, Schalij MJ, Vonk-Noordegraaf A. Early changes in rat hearts with developing pulmonary arterial hypertension can be detected with three-dimensional electrocardiography. Am J Physiol Heart Circ Physiol 2007;293:H1300-H1307. https:\/\/doi.org\/10.1152\/ajpheart.01359.2006","DOI":"10.1152\/ajpheart.01359.2006"},{"key":"ref93","doi-asserted-by":"crossref","unstructured":"Moore EE, Jefferson AL. Impact of cardiovascular hemodynamics on cognitive aging. Arterioscler Thromb Vasc Biol 2021;41:1255-1264. https:\/\/doi.org\/10.1161\/ATVBAHA.120.311909","DOI":"10.1161\/ATVBAHA.120.311909"},{"key":"ref94","doi-asserted-by":"publisher","unstructured":"Kramer AF, Erickson KI, Colcombe SJ. Exercise, cognition, and the aging brain. J Appl Physiol (1985) 2006;101:1237-1242. https:\/\/doi.org\/10.1152\/japplphysiol.00500.2006","DOI":"10.1152\/japplphysiol.00500.2006"},{"key":"ref95","doi-asserted-by":"publisher","unstructured":"Silva V, Campos C, S\u00e1 A, Cavadas M, Pinto J, Sim\u00f5es P, Machado S, Murillo-Rodr\u00edguez E, Barbosa-Rocha N. Wii-based exercise program to improve physical fitness, motor proficiency and functional mobility in adults with Down syndrome. J Intellect Disabil Res 2017;61:755-765. https:\/\/doi.org\/10.1111\/jir.12384","DOI":"10.1111\/jir.12384"},{"key":"ref96","doi-asserted-by":"publisher","unstructured":"Mendonca GV, Pereira FD, Fernhall B. Heart rate recovery and variability following combined aerobic and resistance exercise training in adults with and without Down syndrome. Res Dev Disabil 2013;34:353-361. https:\/\/doi.org\/10.1016\/j.ridd.2012.08.023","DOI":"10.1016\/j.ridd.2012.08.023"},{"key":"ref97","doi-asserted-by":"publisher","unstructured":"Giagkoudaki F, Dimitros E, Kouidi E, Deligiannis A. Effects of exercise training on heart-rate-variability indices in individuals with Down Syndrome. J Sport Rehabil 2010;19:173-183. https:\/\/doi.org\/10.1123\/jsr.19.2.173","DOI":"10.1123\/jsr.19.2.173"},{"key":"ref98","unstructured":"Durstine JL, Moore GE. ACSM's Exercise Management For Persons With Chronic Diseases And Disabilities. 3rd Edition. Human Kinetics, 2009, 456 p."},{"key":"ref99","doi-asserted-by":"publisher","unstructured":"Ladage D, Schwinger RH, Brixius K. Cardio-selective beta-blocker: pharmacological evidence and their influence on exercise capacity. Cardiovasc Ther 2013;31:76-83. https:\/\/doi.org\/10.1111\/j.1755-5922.2011.00306.x","DOI":"10.1111\/j.1755-5922.2011.00306.x"}],"container-title":["Physiological Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T12:26:30Z","timestamp":1648211190000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.biomed.cas.cz\/physiolres\/pdf\/2022\/71_1.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":100,"URL":"https:\/\/doi.org\/10.33549\/physiolres.934791","relation":{},"ISSN":["1802-9973","0862-8408"],"issn-type":[{"value":"1802-9973","type":"electronic"},{"value":"0862-8408","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,22]]}}}